A metabonomic analysis of urine from rats treated with rhizoma alismatis using ultra-performance liquid chromatography/mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 25, Issue 18, 2011, Pages 2633-2640

  Yu, Yue ^a   Ma, Chao ^a   Bi, Kaishun ^a   Yang, Guoguang ^a   Xie, Pu ^a   Wang, Jie ^a   Chen, Xiao Hui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKERS; BODY FLUIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRINCIPAL COMPONENT ANALYSIS;

HISTOPATHOLOGICAL ANALYSIS; IONIZATION MODES; METABONOMIC ANALYSIS; METABONOMICS; NEPHROTOXICITY; PRINCIPAL-COMPONENT ANALYSIS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRIES; ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; URINE SAMPLE;

RATS;

EID: 80052605319     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.5163     Document Type: Article

References (47)

1. B. Makabel, Y. Y. Zhao, B. Wang, Y. J. Bai, Q. Y. Zhang, L. Wu, Y. Lv. Stability and structure studies on alisol A 24-acetate. Chem. Pharm. Bull. 2008, 56, 41.
2. W. F. Fong, C. Wang, G. Y. Zhu, C. H. Leung, M. S. Yang. Reversal of multidrug resistance in cancer cells by rhizoma alismatis extract. Phytomedicine 2007, 14, 160.
3. Institute of Materia Medica, Zhejiang Province People's Health Administration. The pharmaco-research of rhizoma alismatis on lowing blood-fat. Chin. Tradit. Herbal. Drugs 1976, 7, 26.
4. T. Ding, Adverse Reactions, Prevention, and Cures of Chinese Herbal Medicine, China Press of Traditional Chinese Medicine, Beijing, 1992.
5. K. J. Boudonck, M. W. Mitchell, L. Német, L. Keresztes, A. Nyska, D. Shinar, M. Rosenstock. Discovery of metabolomics biomarkers for early detectionof nephrotoxicity. Toxicol. Pathol. 2009, 37, 280.
6. J. K. Nicholson, J. C. Lindon, E. Holmes. 'Metabonomics' understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29, 1181.
7. R. D. Beger, J. Sun, L. K. Schnackenberg. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol. Appl. Pharmacol. 2010, 243, 154.
8. J. C. Lindon, J. K. Nicholson, E. Holmes, The Handbook of Metabonomics and Metabolomics, Elsevier, Amsterdam, 2007.
9. S. Cai, T. G. Huo, J. H. Xu, X. M. Lu, S. N. Zheng, F. M. Li. Effect of mitiglinide on Streptozotocin-induced experimental type 2 diabetic rats: a urinary metabonomics study based on ultra-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2009, 877, 3619.
10. W. Chan, Z. W. Cai. Aristolochic acid induced changes in the metabolic profile of rat urine. J. Pharm. Biomed. Anal. 2008, 46, 757.
11. KEGG. Available: http://www.genome.jp/kegg/.
12. MassBank. Available: http://www.massbank.jp/
13. HMDB. Available: http://www.hmdb.ca/search/spectra? type=ms-ms search.
14. METLIN. Available: http://metlin. scripps.edu/.
15. N. J. Li, W. T. Liu, W. Li, S. Q. Li, X. H. Chen, K. S. Bi, P. He. Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry. Clin. Biochem. 2010, 43, 992.
16. C. Ma, K. S. Bi, D. Su, W. Ji, M. Zhang, X. X. Fan, C. Wang, X. H. Chen. A serum and kidney metabolic changes of rat nephrotoxicity induced by Morning Glory Seed. Food Chem. Toxicol. 2010, 48, 2988.
17. Y. Y. Zhen, K. W. Krausz, C. Chen, J. R. Idle, F. J. Gonzalez. Metabolomic and genetic analysis of biomarkers for peroxisome proliferator activated receptor {alpha} expression and activation. Mol. Endocrinol. 2007, 21, 2136.
18. J. Wang, T. Reijmers, L. J. Chen, R. V. D. Heijden, M. Wang, S. Q. Peng, T. Hankemeier, G. W. Xu, J. Van der Greef. Systems toxicology study of doxorubicin on rats using ultra performance liquid chromatography coupled with mass spectrometry based metabolomics. Metabolomics 2009, 5, 407.
19. E. Lackner, A. Levinson, W. Morse. The role of the liver in hippuric acid synthesis. Biochem. J. 1918, 12, 184.
20. A. Knoflach, U. Binswanger. Serum hippuric acid concentration in renal allograft rejection, ureter obstruction, and tubular necrosis. Transpl. Int. 1994, 7, 17.
21. A. W. Nicholls, R. J. Mortishire-Smith, J. K. Nicholson. NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem. Res. Toxicol. 2003, 16, 1395.
22. Y. Wang, H. Tang, J. K. Nicholson, P. J. Hylands, J. Sampson, E. Holmes. A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. J. Agric. Food Chem. 2005, 53, 191.
23. State Administration of Traditional Chinese Medicine. Chinese Materia Medica, Shanghai scientific & Technical Publishers, Shanghai, 2004.
24. E. Bohus, M. Coen, H. C. Keun, T. M. D. Ebbels, J. C. Lindon, E. Holmes, B. Nosza, J. K. Nicholson. Temporal metabonomic modeling of L-arginine-induced exocrine pancreatitis. J. Proteome. Res. 2008, 7, 4435.
25. A. W. Nicholls, J. K. Nicholson, J. N. Haselden, C. J. Waterfield. A metabonomic approach to the investigation of drug-induced phospholipidosis: an NMR spectroscopy and pattern recognition study. Biomarkers 2000, 5, 410.
26. M. Wyss. Creatine and creatine metabolism. Physiol. Rev. 2000, 80, 1107.
27. The Human Metabolome Database. http://www.hmdb.ca/metabolites/HMDB00562.
28. D. Bishop-Bailey. Peroxisome proliferator-activated receptors in the cardiovascular system. Br. J. Pharmacol. 2000, 129, 823.
29. S. A. Smith. Peroxisome proliferator-activated receptors and the regulation of mammalian lipid metabolism. Biochem. Soc. Trans. 2002, 30, 1086.
30. Y. Guan, M. D. Breyer. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. Kidney Int. 2001, 60, 14.
31. S. Chitturi, G. C. Farrell. Etiopathogenesis of nonalcoholic steatohepatitis. Semin. Liver Dis. 2001, 21, 27.
32. X. Z. Hong. Research of the efficacy and the mechanism of the Alisma orientalis methanolic extract on nonalcoholic fatty liver disease. Master Thesis, Zhejiang University, Zhejiang, 2006.
33. K. A. MB ChB Nath, S. M. MD Norby. Reactive oxygen species and acute renal failure. Am. J. Med. 2000, 109, 665.
34. V. M. Craddock, P. N. Magee. Effect of administration of the carcinogen dimethylnitrosamine on urinary 7-methylguanine. Biochem. J. 1967, 104, 435.
35. K. Tamae, K. Kawai, S. Yamasaki, K. Kawanami, M. Ikeda, K. Takahashi, T. Miyamoto, N. Kato, H. Kasai. Effect of age, smoking and other lifestyle factors on urinary 7-methylguanine and 8-hydroxydeoxyguanosine. Cancer Sci. 2009, 100, 715.
36. L. Buhl, C. Dragsholt, P. Svendsen, E. Hage, M. R. Buhl. Urinary hypoxanthine and pseudouridine as indicators of tumor development in mesothelioma-transplanted nude mice. Cancer Res. 1985, 45, 1159.
37. 1H NMR and HPLC-TOF/MS: time dependant changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity. Analyst 2004, 129, 535.
38. C. M. Palmeira, A. P. Rolo. Mitochondrially-mediated toxicity of bile acids. Toxicology 2004, 203, 1.
39. J. D. Ostrow, in Hepatic Transport and Bile Secretion: Physiology and Pathophysiology, (Eds: N. Tavolin, P. D. Berk). Raven Press, New York, 1993, pp. 673-712.
40. D. Rudman, F. E. Kendall. Bile acid content of human serum II. The binding of cholanic acid by human plasma proteins. J. Clin. Invest. 1957, 36, 538.
41. I. M. Weiner, J. E. Glasser, L. Lack. Renal excretion of bile acids: taurocholic, glycocholic and cholic acids. Am. J. Physiol. 1964, 2076, 964.
42. S. Barnes, J. L. Gollan, B. H. Billing. The role of tubular reabsorption in the renal excretion of bile acids. Biochem. J. 1977, 166, 65.
43. B. Kaler, T. Karram, W. A. Morgan, P. H. Bach, I. M. Yousef, A. Bomzon. Are bile acids involved in the renal dysfunction of obstructive jaundice? An experimental study in bile duct ligated rats. Ren. Fail. 2004, 26, 507.
44. E. N. Wardle. Renal failure in obstructive jaundice-pathogenic factors. Postgrad. Med. J. 1975, 51, 512.
45. W. A. Morgan, Y. Dingg, P. H. Bach. The relationship between sodium chloride concentration and bile acid cytotoxicity in cultured kidney cells. Ren. Fail. 1998, 20, 441.
46. H. Riezman. Organization and functions of sphingolipid biosynthesis in yeast. Biochem. Soc. Trans. 2006, 34, 367.
47. T. O. Messmer, E. Wang, V. L. Stevens, A. H. Merrill, Jr. Sphingolipid biosynthesis by rat liver cells: effects of serine, fatty acids and lipoproteins. J. Nutr. 1989, 119, 534.